Publications

Bylsma LC, Gillezeau C, Garawin T, Kelsh M, Fryzek J, Sangare L, Lowe KA. Prevalence of RAS and BRAF mutations in Metastatic Colorectal Cancer (mCRC) patients by tumor location. Presented at the Gastrointestinal Cancers Symposium, San Francisco, CA, January 2018.

Reichert H, Fryzek J, Bylsma LC. Survival synthesis: Methods for meta-analysis of survival rates and aggregation of survival data. Presented at the 12th International Conference on Health Policy Statistics, Charleston, SC, January 2018.

Broome C, Cunningham JM, Mullins M, Jiang X, Bylsma L, Fryzek J, Rosenthal A. Incidence of thromboembolic events is increased in a retrospective analysis of a large cold agglutinin disease (CAD) cohort. Presented at the American Society of Hematology, Atlanta, GA, December 2017.

Bare JL, Abramson MM, Barlow CA, Scott PK. 2017. Use of air dispersion modeling to estimate historical community exposure from manufacturers of asbestos-containing products. Abstract P.96, Society for Risk Analysis (SRA) Annual Meeting, Arlington, VA, December 2017.

Ruzin A, Levin-Sparenberg E, Pastula S, Jiang X, Fryzek J, Tovchigrechko A, Lu B, Yu L, et al. Characterization of RSV strains among U.S. patients in the OUTSMART RSV program during 2015-16. Abstract and poster presentation, ID Week 2017, San Diego, CA, October 2017.

Jackson M, Yang L, Yauk CL, Lea I, Kuo B, Williams A, Rashid A, Fostel J. The TGx-28.65 biomarker — A web-based application using transcriptomics to identify DNA damage-inducing chemicals. Abstract 1224. Presented at the 48th Annual Meeting of Environmental Mutagenesis and Genomics Society, Raleigh, NC, September 2017.

Soff GA, Ray-Coquard I, Marfil Rivera LJ, Fryzek J, Mullins M, Bylsma LC, Park JK. Literature review of thrombopoietin receptor agonists (TPO-RA) for chemotherapy-induced thrombocytopenia (CIT). Presented at the European Society for Medical Oncology 2017 Congress, Madrid, Spain, September 2017.

Sheppard A, Baker E, Bermudez D, Blattner J, Boyd K, O’Neal S, Rahim T, Whittle E. Implementing an alternate testing strategy for assessing skin irritation. Abstract #2734, Society of Toxicology 56th Annual Meeting, Baltimore, MD, 2017.

Sheppard A, Baker E, Bermudez D, Blattner J, Boyd K, O’Neal S, Rahim T, Whittle E. Use of alternative methods to assess skin irritation of chemical mixtures. World Congress for Alternatives to Animal Testing, Seattle, WA, 2017.

Gadupudi GS, Klaren WD, Olivier AK, Klingelhutz AJ, Robertson LW. Diminished phosphorylation of CREB Is a key event in the dysregulation of gluconeogenesis, glycogenolysis and fatty acid oxidation in PCB126 hepatotoxicity. Society of Toxicology 56th Annual Meeting, Baltimore, MD, and NIEHS Environmental Health Science FEST, Durham, NC, 2017.

Garabrant D, Pastula S. Asbestos and EMP fiber potency analysis. Abstract and oral presentation, Monticello Conference, Charlottesville, VA, October 2017.

Robison TW. Dealing with extractables & leachables from a regulatory perspective: 1. Design of extractables & leachables studies; and 2. Safety assessment of leachables. Smithers Rapra Extractables and Leachables USA Annual Meeting, 2017.

Wikoff DS, Rager JE, Harvey S, Haws L, Chappell G, Borghoff S. Development and refinement of a framework for quantitative consideration of study quality and relevance in the evaluation of mechanistic data based on key characteristics of carcinogens. Society of Risk Analysis Annual Meeting, Arlington, VA, December 2017.

Wikoff DS, Welsh BT, Henderson R, Brorby G, Britt J, Myers E, Goldberger J, Lieberman HR, O’Brien C, Doepker C. Application of systematic reviews in the evaluation of caffeine safety: Potential adverse effects of caffeine consumption in healthy adults, pregnant women, adolescents, and children. Society of Risk Analysis Annual Meeting. December 10-14, 2017. Arlington, VA.

Rish W. Bounding analysis of drinking water health risks from a spill of hydraulic fracturing flowback water. Presented at the Marcellus Shale Coalition Member Meeting, Pittsburgh, PA, January 2017.

Young LE, Sacks NC, Cyr PL, Sharma A, Dahdal DH. Rates of hospitalization and repeat procedures in patients receiving sodium picosulfate/magnesium citrate bowel preparation prior to colonoscopy. Society of Gastroenterology Nurses and Associates, New Orleans LA, 2017.

Frausto SF, Sacks NC, Cyr PL, Sharma A, Dahdal DH, Brogadir S. Hospitalization for hyponatremia and dehydration in patients receiving sodium picosulfate/magnesium citrate bowel preparation prior to colonoscopy. World Congress of Gastroenterology-ACG 2017, Orlando, FL, October 2017.

Young LE, Sacks NC, Cyr PL, Sharma A, Dahdal DH, Brogadir S. Rates of incomplete and repeat screens in patients receiving sodium picosulfate/magnesium citrate bowel preparation prior to colonoscopy versus other low volume bowel preparations. World Congress of Gastroenterology ACG, 2017.

Wu E, Jensen IS, Cyr PL, Kisner H. Economic model shows that guideline recommended testing of patients with early symptoms of myeloma results in improved patient outcomes and decreased hospital costs. American Society of Hematology, Atlanta GA, 2017.

Jensen IS, Wu E, Cyr PL, Gauden D. Cost-consequence of use of Fluciclovine (F 18) for the diagnosis and staging of recurring prostate cancer. ISPOR 16th Annual European Congress, Glasgow, Scotland, 2017.